UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/250/0.01/18.12.24 Share Price

Warrant

H247T

DE000HC8FEF1

Market Closed - Euronext Paris 17:30:01 31/05/2024 BST
0.08 EUR -.--% Intraday chart for UNICREDIT BANK/CALL/SARTORIUS STEDIM BIO/250/0.01/18.12.24
Current month-50.00%
1 month-50.00%
Date Price Change
30/05/24 0.08 -.--%
29/05/24 0.08 -11.11%
28/05/24 0.09 -.--%
27/05/24 0.09 -18.18%
24/05/24 0.11 +10.00%

Real-time Euronext Paris

Last update May 31, 2024 at 05:30 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying SARTORIUS STEDIM BIOTECH
IssuerLogo Issuer UniCredit UniCredit
H247T
ISINDE000HC8FEF1
Date issued 03/08/2023
Strike 250
Maturity 18/12/2024 (201 Days)
Parity 100 : 1
Emission price-
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.72
Lowest since issue 0.07
Delta0.26x
Omega 5.541
Premium41.53x
Gearing21.49x
Moneyness 0.7306
Difference Strike 67.35
Difference Strike %+26.94%
Spread 0.01
Spread %11.11%
Theoretical value 0.0850
Implied Volatility 47.71 %
Total Loss Probability 84.23 %
Intrinsic value 0.000000
Present value 0.0850
Break even 258.50 €
Theta-0x
Vega0x
Rho0x

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Sector
-
More about the company

Ratings for Sartorius Stedim Biotech

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Sartorius Stedim Biotech

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
182.6 EUR
Average target price
248.8 EUR
Spread / Average Target
+36.24%
Consensus
  1. Stock Market
  2. Warrants
  3. H247T Warrant